TP53 and cervical carcinoma: Since Storey et al. [63] reported that individuals homozygous for p53Arg were seven times more susceptible to HPV-associated cervical carcinogenesis than heterozygotes, many groups have investigated the effect of p53 codon 72 polymorphism on cervical cancer risk.